AU6514296A - Heterocyclic compounds, their preparation and use - Google Patents

Heterocyclic compounds, their preparation and use

Info

Publication number
AU6514296A
AU6514296A AU65142/96A AU6514296A AU6514296A AU 6514296 A AU6514296 A AU 6514296A AU 65142/96 A AU65142/96 A AU 65142/96A AU 6514296 A AU6514296 A AU 6514296A AU 6514296 A AU6514296 A AU 6514296A
Authority
AU
Australia
Prior art keywords
preparation
heterocyclic compounds
heterocyclic
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU65142/96A
Other languages
English (en)
Inventor
Anders Kanstrup
Jane Marie Lundbeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU6514296A publication Critical patent/AU6514296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU65142/96A 1995-07-31 1996-07-31 Heterocyclic compounds, their preparation and use Abandoned AU6514296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK87095 1995-07-31
DK870/95 1995-07-31
PCT/DK1996/000332 WO1997005109A1 (fr) 1995-07-31 1996-07-31 Composes heterocycliques, leur preparation et utilisation

Publications (1)

Publication Number Publication Date
AU6514296A true AU6514296A (en) 1997-02-26

Family

ID=8098461

Family Applications (1)

Application Number Title Priority Date Filing Date
AU65142/96A Abandoned AU6514296A (en) 1995-07-31 1996-07-31 Heterocyclic compounds, their preparation and use

Country Status (4)

Country Link
EP (1) EP0843660A1 (fr)
JP (1) JPH11509847A (fr)
AU (1) AU6514296A (fr)
WO (1) WO1997005109A1 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
DE19801647A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
AU2241400A (en) 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
DE60009116T2 (de) 1999-10-15 2005-02-17 F. Hoffmann-La Roche Ag Benzodiazepinderivate und deren verwendung als metabotrope glutamatrezeptor antagonisten
PT1224174E (pt) * 1999-10-15 2004-01-30 Hoffmann La Roche Derivados de benzodiazepina como antagonistas do receptor metabotropico do glutamato
CA2580221A1 (fr) * 2004-10-05 2006-04-13 Merz Pharma Gmbh & Co. Kgaa Nouvelles propenones cycliques et acycliques destinees au traitement des troubles du snc
KR20080023680A (ko) 2005-05-10 2008-03-14 인터뮨, 인크. 스트레스-활성화 단백질 키나제 시스템을 조절하기 위한피리돈 유도체
EP2578216A1 (fr) 2006-11-22 2013-04-10 Seaside Therapeutics, Inc. Procédés de traitement du syndrome de l'X fragile
BRPI0810655A2 (pt) 2007-04-19 2014-11-04 Hoffmann La Roche Derivados de di-hidro-benzo[b][1,4] diazepin-2-ona sulfonamida
MX2010012848A (es) 2008-06-03 2011-03-01 Intermune Inc Compuestos y metodos para tratar trastornos inflamatorios y fibroticos.
WO2011109398A2 (fr) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Procédés et compositions pour le traitement du syndrome d'angelman et des troubles du spectre autistique
US20110294879A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
WO2012009646A1 (fr) 2010-07-15 2012-01-19 Xenoport, Inc. Méthodes de traitement du syndrome de l'x fragile, du syndrome de down, de l'autisme et de troubles associés
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN106459042B (zh) 2014-04-02 2019-06-28 英特穆恩公司 抗纤维化吡啶酮类
EP3455207A4 (fr) * 2016-05-12 2019-10-09 Regents of the University of Minnesota Composés indole et indazole cyanocinnamate et leurs utilisations thérapeutiques

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931230A (en) * 1974-04-12 1976-01-06 Warner-Lambert Company 3-Substituted isotryptamine derivatives and process for their production
KR0178469B1 (ko) * 1990-07-16 1999-03-20 메이나드 알. 존슨 흥분성 아미노산 길항제
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity

Also Published As

Publication number Publication date
JPH11509847A (ja) 1999-08-31
EP0843660A1 (fr) 1998-05-27
WO1997005109A1 (fr) 1997-02-13

Similar Documents

Publication Publication Date Title
AU6514196A (en) Heterocyclic compounds, their preparation and use
AU1106195A (en) Heterocyclic compounds, their preparation and use
AU6124196A (en) Novel dolastatin derivatives, their preparation and use
AU4009795A (en) Heterocyclic compounds and their use
AU7550398A (en) Heterocyclic compounds, their production and use
AU6514296A (en) Heterocyclic compounds, their preparation and use
AU4329396A (en) Use of 3,4-diphenylchromans
AU679887B2 (en) Azole derivatives, their use, production and usage
AU6016896A (en) Heterocyclic compounds, their production and use
AU7095296A (en) Phosphorylamides, their preparation and use
AU6658596A (en) Substituted 1-phenyluracil derivatives, their preparation and their use as herbicides
AU1504495A (en) Substituted heterocyclic carboxamidoesters, their preparation and their use as pharmaceuticals
AU4675596A (en) Azole compounds, their production and use
AU4509696A (en) 3-benzoylpyridine derivatives, their preparation and their use as herbicides
AU3467697A (en) 3'-oximino-2',3'-dideoxynucleosides and derivatives of the same
AU1081897A (en) Heterocyclic compounds and their use
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
AU2563895A (en) 4-benzoylisoxazole derivatives and their use as herbicides
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
AU7001396A (en) Triazole compounds, their production and use
AU5557698A (en) Novel calpaines, their preparation and use
AU2152497A (en) Heterocyclic compounds and their preparation and use
AU5272296A (en) Benzopyranopyrrole compounds, their preparation and use
AU5815696A (en) N-aminopyridone derivatives and their use as herbicides
AU6298196A (en) Tetrahydro-betacarboline derivatives and their preparation and use